TCN’s Emerging ASX Gems Investment Conference
Interview with Dr Michael Thurn about the Phase 1 clinical trial in motor neurone disease” – 13 October 2023
Canine Veterinary Product Update” – 9 October 2023
Dr Michael Thurn PharmAust (PAA) CEO interview on the 09.10.23
A World Without MND Webinar 2023
Pharmaust (ASX:PAA) interview with CEO Dr. Michael Thurn
PharmAust’s (PAA) MPL Extends Dogs Lives In Lymphoma Trial
PharmAust ready to trial monepantel on humans to fight motor neurone disease
PharmAust progresses flagship Monepantel drug in treating canine lymphoma and COVID-19
Monsoon Communications Twilight Webinar – November 2021
PharmAust AGM 2021
Virtual Investor Briefing – August 2021
Q-Wrapz: Oriel Morrison interviews Roger Aston, executive chairman of PharmAust Ltd (ASX:PAA)
PharmAust progresses flagship Monepantel drug in treating canine lymphoma and COVID-19
Epichem OHD Presentation – Waste To Fuels Technology
PharmAust Webinar – Feb 11th
PharmAust Limited AGM 2020
Auzbiz Interview with Dr Richard Mollard – September 2020
PAA awarded a grant for Phase I trial in Motor Neurone Disease
PharmAust confirms Monepantel’s anti-viral potential in the fight against COVID-19
Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
PharmAust Virtual Investor Briefing – June 2020
PAA Speech at Med-Tech & Healthcare Investors Night – July 2019
90 Seconds With Spark – PharmAust (ASX:PAA)
Dr Martine Keenan – CEO and Head of Drug Discovery Interview
Proactive Investors Interview with Dr Roger Aston, Executive Chairman of PharmAust (PAA)
PharmAust: New Drug Entering Phase 2 Trials Targeting Multiple Cancers
Interview on RedChip Money Report television program aired on Bloomberg the 2nd and 3rd of January 2016
PharmAust: Developing Targeted Cancer Therapy
Dave Gentry, host of “The RedChip Money Report”, interviews Dr. Roger Aston, Executive Chairman of PharmAust Ltd (ASX: PAA) as aired on Bloomberg TV.
PharmAust Presentation at RedChip’s February 2016 Conference
PharmAust presentation at the RedChip Global Online Microcap Conference on Thursday, February 11, 2016.